Back to results
US 2021/0087141 A1Published application
Compounds having s1p5 receptor agonistic activity
AssigneeOno Pharmaceutical Co., Ltd.
InventorsToshihide WATANABE, Kensuke KUSUMI, Satomi IMAIDE, Toshimitsu ENDO, Takaki KOMIYA, Naomi TSUBURAYA
Life of this patent
Estimating the term…
Abstract
A compound represented by the general formula (V) wherein all the symbols are as defined in the specification, has an improved balance of the agonist activity against the S1P5 receptor relative to the S1P1 receptor, and can thus serve as a therapeutic agent for S1P5-mediated diseases such as schizophrenia and Binswanger's disease and other neurodegenerative diseases.
Claims20
A compound represented by the general formula (V) or a pharmaceutically acceptable salt thereof:
- wherein
- L is a branched or linear chain group composed of atoms selected from a carbon atom, an oxygen atom, a nitrogen atom, and a sulfur atom, in which the number of atoms in the main chain thereof is 3 to 8, and the chain group may contain 1 to 3 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom,
- provided that a carbon atom in L may be substituted with 1 to 13 halogen atoms,
- Y represents
- wherein each group is bound to Z through a bond represented by an arrow,
- A represents a C3-7 cycloalkylene group which may be substituted or a C1-4 alkylene group which may be substituted,
- R1 represents a C1-4 alkyl group, a C3-6 cycloalkyl group which may be substituted with a halogen, a C1-4 alkoxy group which may be substituted with a halogen, a C1-4 haloalkyl group, a halogen atom, or a hydroxy group,
- R2 represents a C1-4 alkyl group, a C1-4 alkoxy group which may be substituted with a halogen, a C1-4 haloalkyl group, a halogen atom, or a hydroxy group,
- R3, R4, and R5 each independently represent a hydrogen atom, a C1-4 alkyl group, a C3-6 cycloalkyl group which may be substituted with a halogen, or a C1-4 haloalkyl group,
- Z represents (1) a carboxyl group which may be substituted with one C1-8 alkyl group, (2) a hydroxy group which may be substituted with one C1-8 alkyl group, (3) a hydroxamic acid group which may be substituted with one to two C1-8 alkyl groups, (4) a sulfonic acid group which may be substituted with one C1-8 alkyl group, (5) a boronic acid group which may be substituted with one to two C1-8 alkyl groups, (6) a carbamoyl group which may be substituted with (i) one to two C1-8 alkyl groups or (ii) one to two sulfonyl groups which may be substituted with a C1-4 alkyl group, (7) a sulfamoyl group which may be substituted with (i) one to two C1-8 alkyl groups or (ii) one to two C2-8 acyl groups, (8) a sulfoximine group which may be substituted with one to two C1-8 alkyl groups, or (9) a tetrazolyl group,
- ring 2 represents a 3- to 7-membered nitrogen-containing heterocycle,
- m represents an integer of 0 to 6,
- n represents an integer of 0 to 5,
- when m is 2 or more, a plurality of R1s may be the same or different, and
- when n is 2 or more, a plurality of R2s may be the same or different,
- provided that each hydrogen atom may be a deuterium atom or a tritium atom.
13 more elements
Dependencies are inferred from the claim text.